NASDAQ:VRPX

Virpax Pharmaceuticals Stock Insider Trading

etoro logo Buy VRPX
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jul 31, 2026

Virpax Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 4.66M and sold 0 VRPX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 4.66M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Sendrow Jerrold
Director
Director 25 000
Value: $8K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Bruce Gerald W
Chief Executive Officer
CEO / President 125 000
Value: $39.7K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Floyd Eric
Director
Director 45 000
Value: $14.3K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Ruskin Barbara
Director
Director 25 000
Value: $8K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Singh Vanila
Director
Director 25 000
Value: $8K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Shah Vinay
Chief Financial Officer
C-Suite Officer 112 000
Value: $35.6K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Jambulingam Thani
Director
Director 25 000
Value: $8K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Mathias Sheila
Chief Scientific Officer
Officer 112 000
Value: $35.6K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Dubin Michael F
Director
Director 25 000
Value: $8K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Sendrow Jerrold
Director
Director 25 000
Value: $8K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Bruce Gerald W
Chief Executive Officer
CEO / President 125 000
Value: $39.7K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Floyd Eric
Director
Director 45 000
Value: $14.3K
Jan 29, 2024
Buy
Stock Option (right to buy)
A-Award
Ruskin Barbara
Director
Director 25 000
Value: $8K
Jan 25, 2024
Buy
Stock Option (Right to buy)
Mathias Sheila
Chief Scientific Officer
Officer 112 000
Value: $88.5K
Jan 25, 2024
Buy
Stock Option (Right to buy)
Mathias Sheila
Chief Scientific Officer
Officer 112 000
Value: $88.5K
Jun 20, 2023
Buy
Stock Option (right to buy)
A-Award
Shah Vinay
Chief Financial Officer
C-Suite Officer 100 000
Value: $99.0K
Jun 20, 2023
Buy
Stock Option (right to buy)
A-Award
Shah Vinay
Chief Financial Officer
C-Suite Officer 100 000
Value: $99.0K
Jun 20, 2023
Buy
Stock Option (right to buy)
A-Award
Shah Vinay
Chief Financial Officer
C-Suite Officer 100 000
Value: $99.0K
Jun 20, 2023
Buy
Common Stock
J-Other
Shah Vinay
Officer
Officer 0
Value: $0
Jun 20, 2023
Buy
Stock Option (right to buy)
A-Award
Shah Vinay
Chief Financial Officer
C-Suite Officer 100 000
Value: $99.0K
Jun 20, 2023
Buy
Common Stock
J-Other
Shah Vinay
Officer
Officer 0
Value: $0
Apr 24, 2023
Buy
Stock Option (right to buy)
A-Award
Bruce Gerald W
Director
Director 100 000
Value: $73.0K
Apr 24, 2023
Buy
Stock Option (right to buy)
A-Award
Bruce Gerald W
Director
Director 100 000
Value: $73.0K
Mar 24, 2023
Buy
Stock Option (right to buy)
A-Award
Ruskin Barbara
Director
Director 25 000
Value: $20.9K
Mar 24, 2023
Buy
Common Stock
J-Other
Ruskin Barbara
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VIRPAX PHARMACEUTICALS, INC.
Virpax Pharmaceuticals
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an inject...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE